Edition:
United States

X T L Biopharmaceuticals Ltd (XTLB.OQ)

XTLB.OQ on NASDAQ Stock Exchange Capital Market

2.96USD
15 Oct 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.96
Open
--
Day's High
--
Day's Low
--
Volume
400
Avg. Vol
3,624
52-wk High
$3.91
52-wk Low
$1.58

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.002
FY 2017 Dec '17 0.00 0.000
Sep '17 0.003
Jun '17 -0.003
Mar '17 -0.003
FY 2016 Dec '16 0.00 -0.003
Sep '16 -0.006
Jun '16 0.00 -0.010
Mar '16 -0.011
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 10.43 119.85 32.14
P/E High - Last 5 Yrs. 65.61 284.29 46.82
P/E Low - Last 5 Yrs. 65.61 95.75 24.71
Beta 0.04 0.63 0.87
Price to Sales (TTM) -- 109.82 6.55
Price to Book (MRQ) 0.18 13.72 4.00
Price to Tangible Book (MRQ) 1.90 20.21 6.10
Price to Cash Flow (TTM) -- 69.50 21.51
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.68
Dividend Yield - 5 Year Avg -- 0.20 1.45
Dividend 5 Year Growth Rate -- 2.61 -5.91
Payout Ratio(TTM) -- 5.68 46.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 157.56 7.91
Sales (TTM) vs TTM 1 Yr. Ago -- 91.25 6.56
Sales - 5 Yr. Growth Rate -- 25.47 7.49
EPS (MRQ) vs Qtr. 1 Yr. Ago 158.22 297.15 26.63
EPS (TTM) vs TTM 1 Yr. Ago 109.46 -- --
EPS - 5 Yr. Growth Rate -- 25.12 7.65
Capital Spending - 5 Yr. Growth Rate -- 39.11 8.16

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.65 2.22
Current Ratio (MRQ) 26.07 5.52 2.99
LT Debt to Equity (MRQ) -- 15.33 11.31
Total Debt to Equity (MRQ) -- 18.80 14.15
Interest Coverage (TTM) -2.18 -216.32 34.46

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 32.64 54.36
Gross Margin - 5 Yr. Avg. -- 52.76 53.16
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -164.07 16.13
Operating Margin (TTM) -- -618.88 3.36
Operating Margin - 5 Yr. Avg. -- -178.92 11.28
Pre-Tax Margin (TTM) -- -615.68 3.79
Pre-Tax Margin - 5 Yr. Avg. -- -181.48 11.54
Net Profit Margin (TTM) -- -604.79 0.60
Net Profit Margin - 5 Yr. Avg. -- -179.91 7.83
Effective Tax Rate (TTM) -- 11.98 20.73
Effective Tax Rate - 5 Yr. Avg. -- 19.65 24.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 24,741,437 725,680,242
Net Income/Employee (TTM) -- 1,102,410 84,001,075
Receivable Turnover (TTM) -- 4.18 5.06
Inventory Turnover (TTM) -- 2.14 3.65
Asset Turnover (TTM) 0.00 0.39 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 15.06 0.35 9.83
Return on Assets - 5 Yr. Avg. -30.36 3.11 10.94
Return on Investment (TTM) 15.93 1.96 12.83
Return on Investment - 5 Yr. Avg. -36.94 2.91 14.05
Return on Equity (TTM) 22.08 1.12 14.95
Return on Equity - 5 Yr. Avg. -35.99 -0.97 15.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 82.13 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for X T L Biopharmaceuticals Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 4.63%
# of Holders: 6
Total Shares Held: 238,137
3 Mo. Net Change: 0
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 0
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.